HALOVSLEXX• 28 Days (Normalized)
HALO vs LEXX (Halozyme Therapeutics Inc. vs Lexaria Bioscience Corp.)
Showing Closing Date Range from Sep 7 to Oct 5, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
HALO Performance $109.86
+1.43%
Halozyme Therapeutics Inc.
Normalized Baseline0.00%
LEXX Performance $2.88
-69.26%
Lexaria Bioscience Corp.
Normalized Baseline0.00%
Alpha Spread Margin HALO LEADS
+70.69 pts
HALO outperforming by 70.69 percentage points
HALOLEXX
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
HALO LEXX
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(19 dates)
| Date | HALO Price | HALO Gain (%) | LEXX Price | LEXX Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 02, 2026 | $109.86 | +1.43% | $2.88 | -69.26% | +70.69% |
| Oct 01, 2026 | $106.94 | -1.26% | $- | - | |
| Sep 30, 2026 | $110.40 | +1.93% | $3.15 | -66.38% | +68.31% |
| Sep 29, 2026 | $111.56 | +3.00% | $3.13 | -66.60% | +69.60% |
| Sep 28, 2026 | $112.89 | +4.23% | $3.23 | -65.58% | +69.81% |
| Sep 25, 2026 | $113.90 | +5.16% | $3.28 | -64.99% | +70.15% |
| Sep 24, 2026 | $- | $3.37 | -64.03% | - | |
| Sep 23, 2026 | $112.44 | +3.81% | $3.24 | -65.47% | +69.28% |
| Sep 22, 2026 | $115.13 | +6.30% | $- | - | |
| Sep 21, 2026 | $111.45 | +2.90% | $3.43 | -63.45% | +66.35% |
| Sep 18, 2026 | $112.45 | +3.82% | $3.24 | -65.42% | +69.24% |
| Sep 17, 2026 | $109.68 | +1.26% | $3.29 | -64.89% | +66.15% |
| Sep 16, 2026 | $108.44 | +0.12% | $3.10 | -66.97% | +67.09% |
| Sep 15, 2026 | $106.25 | -1.90% | $3.21 | -65.74% | +63.84% |
| Sep 14, 2026 | $107.94 | -0.34% | $3.55 | -62.11% | +61.77% |
Page 1 of 2